BACE1 and Alzheimer disease: Studies showed sulforaphane being an effective NRF2 inducer effectively downregulating BACE1 enzymes via upregulating NRF2 target genes, including HO-1, and ameliorating cognitive deficits and preventing accumulation in AD-induced mice models [72].